Showing results (81-90 of 1,054) with videos related to
Sort By:
Pageof 106
The Journal of Cell Biology|June 1, 1987
Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptideD E Brenneman, E A Neale, G A Foster, et al.Brain Research|December 11, 1992
Potent gp120-like neurotoxic activity in the cerebrospinal fluid of HIV-infected individuals is blocked by peptide TJ Buzy, D E Brenneman, C B Pert, et al.Brain Research. Developmental Brain Research|June 8, 1993
Excitatory amino acid regulation of the enkephalin phenotype in mouse embryonic spinal cord culturesR W Summers, X R Wu, S C Fitzgerald, et al.The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptidesD E Brenneman, J Hauser, E Neale, et al.Brain Research|August 14, 1999
VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal deathD E Brenneman, J Hauser, C Y Spong, et al.Journal of Neurochemistry|December 3, 1999
Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced deathG W Glazner, A Boland, A E Dresse, et al.Journal of Neurochemistry|April 1, 1990
Alpha 1-adrenergic receptor mediates arachidonic acid release in spinal cord neurons independent of inositol phospholipid turnoverR Y Kanterman, C C Felder, D E Brenneman, et al.Brain Research|January 20, 1992
Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonistJ R Glowa, L V Panlilio, D E Brenneman, et al.Journal of Molecular Neuroscience : MN|January 1, 1994
Inhibition of human neuroblastoma growth by a specific VIP antagonistG Lilling, Y Wollman, M N Goldstein, et al.Endocrinology|July 19, 2001
IGF-I as a mediator of VIP/activity-dependent neurotrophic factor-stimulated embryonic growthS J Servoss, S J Lee, G Gibney, et al.Pageof 106